Time after Synthesis and Time after Injection Do Not Affect Diagnostic Quality of [<sup>18</sup>F]F-PSMA 1007 PET
PET imaging using PSMA ligands is increasingly used for staging in prostate cancer patients in different clinical indications. Unlike [<sup>68</sup>Ga]Ga-labeled PSMA ligands, fluorinated compounds can be produced in large amounts; thus, they can be used for a higher number of patients....
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-10-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/14/20/5141 |